Stocks might get their September interest-rate cut, but the Federal Reserve could still disappoint the market, as soon as ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...